Stahl's Essential
Psychopharmacology
Neuroscientific Basis and
Practical Applications (5th
Edition) 301 questions and
correct answers from all
chapter 1 to chapter 13
Chapter 1: Chemical Neurotransmission
1. Question: What is the primary function of chemical neurotransmission in the central
nervous system?
Answer: It allows neurons to communicate with one another across synapses using
chemical messenger molecules.
2. Question: Define retrograde signaling.
Answer: A process where a postsynaptic neuron communicates backward to the
presynaptic axon terminal using messengers like endocannabinoids or nitric oxide.
3. Question: What enzyme is responsible for the synthesis of acetylcholine?
Answer: Choline acetyltransferase (ChAT).
4. Question: Which vesicular transporter packs acetylcholine into synaptic vesicles?
Answer: Vesicular acetylcholine transporter (VAChT).
5. Question: What mechanism primarily terminates the action of synaptic norepinephrine?
Answer: Reuptake into the presynaptic terminal via the norepinephrine transporter
(NET).
6. Question: Which amino acid serves as the common precursor for catecholamines?
Answer: Tyrosine.
7. Question: What is the rate-limiting enzyme in catecholamine synthesis?
Answer: Tyrosine hydroxylase.
8. Question: How is serotonin (5-HT) synthesized from its amino acid precursor?
Answer: Tryptophan is converted into 5-hydroxytryptophan (5-HTP) by tryptophan
hydroxylase, followed by decarricopylation via aromatic L-amino acid decarboxylase.
9. Question: What structural classification do most serotonin receptors belong to?
Answer: G-protein coupled receptors (GPCRs), with the sole exception of the 5 - HT 3
receptor, which is a ligand-gated ion channel.
, 10. Question: What role do autoreceptors play on presynaptic terminals?
Answer: They act as a negative feedback loop to inhibit further release or synthesis of
the neurotransmitter.
Chapter 2: Transporters, Receptors, and Enzymes as Targets of
Psychopharmacological Drug Action
11. Question: What is an inverse agonist?
Answer: A drug that binds to a receptor and produces an intrinsic pharmacological
response opposite to that of an agonist, reducing constitutive activity.
12. Question: Define allosteric modulation.
Answer: The binding of a molecule to a distinct site on a receptor (other than the
orthosteric site) that enhances or inhibits the receptor's response to its natural ligand.
13. Question: How do selective serotonin reuptake inhibitors (SSRIs) exert their primary
pharmacological effect?
Answer: By blocking the serotonin transporter (SERT), thereby increasing extracellular
synaptic serotonin levels.
14. Question: What is down-regulation of receptors?
Answer: A process where prolonged exposure to an agonist leads to a decrease in the
total number of cell-surface receptors.
15. Question: What class of enzymes degrades monoamine neurotransmitters inside the
presynaptic terminal?
Answer: Monoamine oxidases (MAO-A and MAO-B).
16. Question: What is meant by "occupancy versus response" in receptor pharmacology?
Answer: The principle that a drug can occupy a percentage of receptors without
necessarily producing a maximal biological response, owing to spare receptors.
17. Question: What distinguishes a partial agonist from a full agonist?
Answer: A partial agonist stimulates the receptor to a lesser degree even when all
receptors are occupied, possessing lower intrinsic efficacy.
18. Question: How do competitive antagonists interact with receptors?
Answer: They bind reversibly to the exact same orthosteric site as the agonist, competing
directly for binding space.
19. Question: What is signal transduction?
Answer: The molecular cascade initiated by extracellular ligand binding that converts
chemical signals into intracellular functional changes.
20. Question: What role do G-proteins serve in transmembrane signaling?
Answer: They act as molecular switches that couple cell-surface receptors to
downstream intracellular effector enzymes or ion channels.
Chapter 3: Ion Channels as Targets of Psychopharmacological Drug Action
21. Question: What are voltage-gated ion channels primarily sensitive to?
Answer: Changes in the electrical membrane potential across the cell membrane.
22. Question: Which ion channel is the primary pharmacological target for classical mood
stabilizers like lithium and valproate?
, Answer: Voltage-sensitive sodium channels and downstream intracellular signaling
cascades.
23. Question: How do local anesthetics and certain anticonvulsants alter sodium channel
states?
Answer: By preferentially binding to and stabilizing the inactivated state of the voltage-
gated sodium channel.
24. Question: What type of ion channel gate is opened by the binding of neurotransmitters
rather than voltage changes?
Answer: Ligand-gated ion channels (ionotropic receptors).
25. Question: Which ion influx is typically mediated by activation of the NMDA receptor?
+¿ ¿
Answer: Calcium (C a2+¿¿ ) and sodium ( N a ) influx.
26. Question: What blocks the NMDA receptor pore at resting membrane potentials?
Answer: Extracellular magnesium ions ( M g 2+¿¿).
27. Question: What physiological event relieves magnesium blockade at NMDA channels?
Answer: Depolarization of the postsynaptic membrane.
28. Question: How do benzodiazepines interact with GAB A A receptors?
Answer: They act as positive allosteric modulators (PAMs) at a site distinct from the
GABA binding site, increasing frequency of channel opening.
29. Question: What major ion flows through the GAB A A receptor complex when activated?
Answer: Chloride ions (C l −¿ ¿).
30. Question: What is the net effect of GAB A A receptor activation on neuronal excitability?
Answer: Hyperpolarization, leading to inhibition of action potential firing.
Chapter 4: Psychosis, Schizophrenia, and Neurotransmitter Networks
31. Question: What is the traditional dopamine hypothesis of schizophrenia?
Answer: The theory that schizophrenia symptoms are caused by hyperactive
dopaminergic transmission, particularly in subcortical mesolimbic pathways.
32. Question: Which brain pathway is implicated in the positive symptoms of
schizophrenia?
Answer: The mesolimbic dopamine pathway.
33. Question: Hypoactivity in which dopamine pathway is hypothesized to cause negative
and cognitive symptoms of schizophrenia?
Answer: The mesocortical dopamine pathway.
34. Question: What role does the nigrostriatal dopamine pathway play in motor control?
Answer: It facilitates purposeful movement via projections from the substantia nigra to
the basal ganglia.
35. Question: Blockade of dopamine in which pathway leads to hyperprolactinemia?
Answer: The tuberoinfundibular dopamine pathway.
36. Question: How does serotonin interact with dopamine release in the striatum?
Answer: Serotonin typically inhibits dopamine release via 5 - HT 2 receptors.
37. Question: What is the glutamate hypothesis of schizophrenia centered around?
Answer: Hypofunction of NMDA receptors on cortical GABAergic interneurons.
38. Question: How does NMDA receptor hypofunction on interneurons lead to cortical
glutamate excess?
Answer: Disinhibition of pyramidal neurons, causing excitotoxic surges of glutamate.
Psychopharmacology
Neuroscientific Basis and
Practical Applications (5th
Edition) 301 questions and
correct answers from all
chapter 1 to chapter 13
Chapter 1: Chemical Neurotransmission
1. Question: What is the primary function of chemical neurotransmission in the central
nervous system?
Answer: It allows neurons to communicate with one another across synapses using
chemical messenger molecules.
2. Question: Define retrograde signaling.
Answer: A process where a postsynaptic neuron communicates backward to the
presynaptic axon terminal using messengers like endocannabinoids or nitric oxide.
3. Question: What enzyme is responsible for the synthesis of acetylcholine?
Answer: Choline acetyltransferase (ChAT).
4. Question: Which vesicular transporter packs acetylcholine into synaptic vesicles?
Answer: Vesicular acetylcholine transporter (VAChT).
5. Question: What mechanism primarily terminates the action of synaptic norepinephrine?
Answer: Reuptake into the presynaptic terminal via the norepinephrine transporter
(NET).
6. Question: Which amino acid serves as the common precursor for catecholamines?
Answer: Tyrosine.
7. Question: What is the rate-limiting enzyme in catecholamine synthesis?
Answer: Tyrosine hydroxylase.
8. Question: How is serotonin (5-HT) synthesized from its amino acid precursor?
Answer: Tryptophan is converted into 5-hydroxytryptophan (5-HTP) by tryptophan
hydroxylase, followed by decarricopylation via aromatic L-amino acid decarboxylase.
9. Question: What structural classification do most serotonin receptors belong to?
Answer: G-protein coupled receptors (GPCRs), with the sole exception of the 5 - HT 3
receptor, which is a ligand-gated ion channel.
, 10. Question: What role do autoreceptors play on presynaptic terminals?
Answer: They act as a negative feedback loop to inhibit further release or synthesis of
the neurotransmitter.
Chapter 2: Transporters, Receptors, and Enzymes as Targets of
Psychopharmacological Drug Action
11. Question: What is an inverse agonist?
Answer: A drug that binds to a receptor and produces an intrinsic pharmacological
response opposite to that of an agonist, reducing constitutive activity.
12. Question: Define allosteric modulation.
Answer: The binding of a molecule to a distinct site on a receptor (other than the
orthosteric site) that enhances or inhibits the receptor's response to its natural ligand.
13. Question: How do selective serotonin reuptake inhibitors (SSRIs) exert their primary
pharmacological effect?
Answer: By blocking the serotonin transporter (SERT), thereby increasing extracellular
synaptic serotonin levels.
14. Question: What is down-regulation of receptors?
Answer: A process where prolonged exposure to an agonist leads to a decrease in the
total number of cell-surface receptors.
15. Question: What class of enzymes degrades monoamine neurotransmitters inside the
presynaptic terminal?
Answer: Monoamine oxidases (MAO-A and MAO-B).
16. Question: What is meant by "occupancy versus response" in receptor pharmacology?
Answer: The principle that a drug can occupy a percentage of receptors without
necessarily producing a maximal biological response, owing to spare receptors.
17. Question: What distinguishes a partial agonist from a full agonist?
Answer: A partial agonist stimulates the receptor to a lesser degree even when all
receptors are occupied, possessing lower intrinsic efficacy.
18. Question: How do competitive antagonists interact with receptors?
Answer: They bind reversibly to the exact same orthosteric site as the agonist, competing
directly for binding space.
19. Question: What is signal transduction?
Answer: The molecular cascade initiated by extracellular ligand binding that converts
chemical signals into intracellular functional changes.
20. Question: What role do G-proteins serve in transmembrane signaling?
Answer: They act as molecular switches that couple cell-surface receptors to
downstream intracellular effector enzymes or ion channels.
Chapter 3: Ion Channels as Targets of Psychopharmacological Drug Action
21. Question: What are voltage-gated ion channels primarily sensitive to?
Answer: Changes in the electrical membrane potential across the cell membrane.
22. Question: Which ion channel is the primary pharmacological target for classical mood
stabilizers like lithium and valproate?
, Answer: Voltage-sensitive sodium channels and downstream intracellular signaling
cascades.
23. Question: How do local anesthetics and certain anticonvulsants alter sodium channel
states?
Answer: By preferentially binding to and stabilizing the inactivated state of the voltage-
gated sodium channel.
24. Question: What type of ion channel gate is opened by the binding of neurotransmitters
rather than voltage changes?
Answer: Ligand-gated ion channels (ionotropic receptors).
25. Question: Which ion influx is typically mediated by activation of the NMDA receptor?
+¿ ¿
Answer: Calcium (C a2+¿¿ ) and sodium ( N a ) influx.
26. Question: What blocks the NMDA receptor pore at resting membrane potentials?
Answer: Extracellular magnesium ions ( M g 2+¿¿).
27. Question: What physiological event relieves magnesium blockade at NMDA channels?
Answer: Depolarization of the postsynaptic membrane.
28. Question: How do benzodiazepines interact with GAB A A receptors?
Answer: They act as positive allosteric modulators (PAMs) at a site distinct from the
GABA binding site, increasing frequency of channel opening.
29. Question: What major ion flows through the GAB A A receptor complex when activated?
Answer: Chloride ions (C l −¿ ¿).
30. Question: What is the net effect of GAB A A receptor activation on neuronal excitability?
Answer: Hyperpolarization, leading to inhibition of action potential firing.
Chapter 4: Psychosis, Schizophrenia, and Neurotransmitter Networks
31. Question: What is the traditional dopamine hypothesis of schizophrenia?
Answer: The theory that schizophrenia symptoms are caused by hyperactive
dopaminergic transmission, particularly in subcortical mesolimbic pathways.
32. Question: Which brain pathway is implicated in the positive symptoms of
schizophrenia?
Answer: The mesolimbic dopamine pathway.
33. Question: Hypoactivity in which dopamine pathway is hypothesized to cause negative
and cognitive symptoms of schizophrenia?
Answer: The mesocortical dopamine pathway.
34. Question: What role does the nigrostriatal dopamine pathway play in motor control?
Answer: It facilitates purposeful movement via projections from the substantia nigra to
the basal ganglia.
35. Question: Blockade of dopamine in which pathway leads to hyperprolactinemia?
Answer: The tuberoinfundibular dopamine pathway.
36. Question: How does serotonin interact with dopamine release in the striatum?
Answer: Serotonin typically inhibits dopamine release via 5 - HT 2 receptors.
37. Question: What is the glutamate hypothesis of schizophrenia centered around?
Answer: Hypofunction of NMDA receptors on cortical GABAergic interneurons.
38. Question: How does NMDA receptor hypofunction on interneurons lead to cortical
glutamate excess?
Answer: Disinhibition of pyramidal neurons, causing excitotoxic surges of glutamate.
